Indraneil Basu joined Boston Consulting Group in 2014. He is a core member of the Health Care and Principal Investors and Private Equity (PIPE) practices, supporting biopharma, private equity and medtech clients on a range of strategic, operational, and transactional topics.

Since joining BCG, Indraneil has supported leading private equity and biopharma companies across a range of commercial topics and broader organizational strategy, including portfolio strategy and launch excellence, PMI planning and execution, org design and operating model definition, and zero-based budgeting, as well as commercial and vendor due diligences and associated portfolio company work. He has also worked with several leading medtech clients on commercial topics.

Prior to joining BCG, Indraneil was a clinician in the UK National Health Service. He has over 13 years of professional experience in health care and health care consulting.


  • Medical Degree, Cambridge University
  • MSc, nanotechnology, University College London
  • MBA, Warwick Business School